therapeutic_area,overall_loa,typical_timeline_years,notes
Overall,0.067,8.3,Industry average (2014-2023)
Oncology,0.034,9.8,"Low success, long timelines"
Vaccines,0.334,5.7,"High success, faster"
Anti-Infectives,0.176,7.5,Moderate success
Orphan Drugs,0.062,8,"Low overall, high Ph1 success"
